379 related articles for article (PubMed ID: 24565357)
21. Trajectories of change in youth anxiety during cognitive-behavior therapy.
Peris TS; Compton SN; Kendall PC; Birmaher B; Sherrill J; March J; Gosch E; Ginsburg G; Rynn M; McCracken JT; Keeton CP; Sakolsky D; Suveg C; Aschenbrand S; Almirall D; Iyengar S; Walkup JT; Albano AM; Piacentini J
J Consult Clin Psychol; 2015 Apr; 83(2):239-52. PubMed ID: 25486372
[TBL] [Abstract][Full Text] [Related]
22. Initiation of Pharmacotherapy Following CBT in Anxious Youth: Results From the Child/Adolescent Anxiety Multimodal Study (CAMS).
Strawn JR; Mills JA; Rothenberg R; Piacentini J; Peris TS; McCracken JT; Walkup JT
J Clin Psychiatry; 2022 Dec; 84(1):. PubMed ID: 36479955
[No Abstract] [Full Text] [Related]
23. Substance use outcomes from the Child/Adolescent Anxiety Multimodal Extended Long-term Study (CAMELS).
Rabner J; Olino TM; Albano AM; Keeton CP; Sakolsky D; Birmaher B; Piacentini J; Peris TS; Compton SN; Gosch E; Ginsburg GS; Pinney EL; Kendall PC
J Child Psychol Psychiatry; 2024 Jul; 65(7):910-920. PubMed ID: 38217328
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Treatment Expectations on Exposure Process and Treatment Outcome in Childhood Anxiety Disorders.
Wu MS; Caporino NE; Peris TS; Pérez J; Thamrin H; Albano AM; Kendall PC; Walkup JT; Birmaher B; Compton SN; Piacentini J
J Abnorm Child Psychol; 2020 Jan; 48(1):79-89. PubMed ID: 31313062
[TBL] [Abstract][Full Text] [Related]
25. Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale.
Caporino NE; Brodman DM; Kendall PC; Albano AM; Sherrill J; Piacentini J; Sakolsky D; Birmaher B; Compton SN; Ginsburg G; Rynn M; McCracken J; Gosch E; Keeton C; March J; Walkup JT
J Am Acad Child Adolesc Psychiatry; 2013 Jan; 52(1):57-67. PubMed ID: 23265634
[TBL] [Abstract][Full Text] [Related]
26. Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes.
Gordon-Hollingsworth AT; Becker EM; Ginsburg GS; Keeton C; Compton SN; Birmaher BB; Sakolsky DJ; Piacentini J; Albano AM; Kendall PC; Suveg CM; March JS
Child Psychiatry Hum Dev; 2015 Oct; 46(5):643-55. PubMed ID: 25293650
[TBL] [Abstract][Full Text] [Related]
27. Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
Strawn JR; Dobson ET; Mills JA; Cornwall GJ; Sakolsky D; Birmaher B; Compton SN; Piacentini J; McCracken JT; Ginsburg GS; Kendall PC; Walkup JT; Albano AM; Rynn MA
J Child Adolesc Psychopharmacol; 2017 Aug; 27(6):501-508. PubMed ID: 28384010
[TBL] [Abstract][Full Text] [Related]
28. Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trial.
Skarphedinsson G; Weidle B; Thomsen PH; Dahl K; Torp NC; Nissen JB; Melin KH; Hybel K; Valderhaug R; Wentzel-Larsen T; Compton SN; Ivarsson T
Eur Child Adolesc Psychiatry; 2015 May; 24(5):591-602. PubMed ID: 25239489
[TBL] [Abstract][Full Text] [Related]
29. Randomized, placebo-controlled trial of cognitive-behavioral therapy alone or combined with sertraline in the treatment of pediatric obsessive-compulsive disorder.
Storch EA; Bussing R; Small BJ; Geffken GR; McNamara JP; Rahman O; Lewin AB; Garvan CS; Goodman WK; Murphy TK
Behav Res Ther; 2013 Dec; 51(12):823-9. PubMed ID: 24184429
[TBL] [Abstract][Full Text] [Related]
30. Symptom-specific effects of cognitive-behavioral therapy, sertraline, and their combination in a large randomized controlled trial of pediatric anxiety disorders.
Cervin M; Storch EA; Piacentini J; Birmaher B; Compton SN; Albano AM; Gosch E; Walkup JT; Kendall PC
J Child Psychol Psychiatry; 2020 Apr; 61(4):492-502. PubMed ID: 31471911
[TBL] [Abstract][Full Text] [Related]
31. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety.
Walkup JT; Albano AM; Piacentini J; Birmaher B; Compton SN; Sherrill JT; Ginsburg GS; Rynn MA; McCracken J; Waslick B; Iyengar S; March JS; Kendall PC
N Engl J Med; 2008 Dec; 359(26):2753-66. PubMed ID: 18974308
[TBL] [Abstract][Full Text] [Related]
32. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression.
Hilton RC; Rengasamy M; Mansoor B; He J; Mayes T; Emslie GJ; Porta G; Clarke GN; Wagner KD; Birmaher B; Keller MB; Ryan N; Shamseddeen W; Asarnow JR; Brent DA
J Am Acad Child Adolesc Psychiatry; 2013 May; 52(5):482-92. PubMed ID: 23622849
[TBL] [Abstract][Full Text] [Related]
33. Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.
Wang Z; Whiteside SPH; Sim L; Farah W; Morrow AS; Alsawas M; Barrionuevo P; Tello M; Asi N; Beuschel B; Daraz L; Almasri J; Zaiem F; Larrea-Mantilla L; Ponce OJ; LeBlanc A; Prokop LJ; Murad MH
JAMA Pediatr; 2017 Nov; 171(11):1049-1056. PubMed ID: 28859190
[TBL] [Abstract][Full Text] [Related]
34. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
[TBL] [Abstract][Full Text] [Related]
35. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
[TBL] [Abstract][Full Text] [Related]
36. Combining CBT and sertraline does not enhance outcomes for anxious youth: a double-blind randomised controlled trial.
Hudson JL; McLellan LF; Eapen V; Rapee RM; Wuthrich V; Lyneham HJ
Psychol Med; 2023 Apr; 53(5):1741-1749. PubMed ID: 34463234
[TBL] [Abstract][Full Text] [Related]
37. Pilot of a randomised controlled trial of the selective serotonin reuptake inhibitor sertraline versus cognitive behavioural therapy for anxiety symptoms in people with generalised anxiety disorder who have failed to respond to low-intensity psychological treatments as defined by the National Institute for Health and Care Excellence guidelines.
Buszewicz M; Cape J; Serfaty M; Shafran R; Kabir T; Tyrer P; Clarke CS; Nazareth I
Health Technol Assess; 2017 Aug; 21(45):1-138. PubMed ID: 28853392
[TBL] [Abstract][Full Text] [Related]
38. Tics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.
Skarphedinsson G; Compton S; Thomsen PH; Weidle B; Dahl K; Nissen JB; Torp NC; Hybel K; Melin KH; Valderhaug R; Wentzel-Larsen T; Ivarsson T
J Child Adolesc Psychopharmacol; 2015 Jun; 25(5):432-9. PubMed ID: 26091197
[TBL] [Abstract][Full Text] [Related]
39. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
[TBL] [Abstract][Full Text] [Related]
40. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
